CIBC Private Wealth Group
AYTU icon

CIBC Private Wealth Group’s AYTU BioPharma AYTU Stock Holding History

CIBC Private Wealth Group’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$216 Hold
83
– – ﹤0.01% 3198
2025
Q3 		$156 Hold
83
– – ﹤0.01% 2960
2025
Q2 		$181 Hold
83
– – ﹤0.01% 2922
2025
Q1 		$84 Hold
83
– – ﹤0.01% 3002
2024
Q4 		$148 Hold
83
– – ﹤0.01% 2901
2024
Q3 		$195 Hold
83
– – ﹤0.01% 3023
2024
Q2 		$242 Hold
83
– – ﹤0.01% 3044
2024
Q1 		$248 Buy
+83
New +$237 ﹤0.01% 2978

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

CIBC Private Wealth Group's AYTU Position: Q4 2025 in Review

CIBC Private Wealth Group held its AYTU BioPharma (AYTU) position steady in Q4 2025 at 83 shares worth $216. The position accounts for ﹤0.01% of the portfolio, ranked #3198.

CIBC Private Wealth Group first reported a position in AYTU in Q1 2024 and has held it in 8 quarters since. The position peaked at $248 in Q1 2024. 39 funds tracked by Wall St. Rank hold AYTU as of Q4 2025.

  • CIBC Private Wealth Group held 83 shares of AYTU BioPharma worth $216 as of Q4 2025.
  • CIBC Private Wealth Group left its AYTU BioPharma share count unchanged in Q4 2025.
  • AYTU BioPharma made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3198 holding.
  • CIBC Private Wealth Group first reported a position in AYTU BioPharma in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's AYTU BioPharma position peaked at $248 in Q1 2024.
  • 39 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.